Matson, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have jointly filed a Schedule 13G, reporting beneficial ownership of Matson, Inc. common stock.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 4.95% in Matson Inc. common stock as of June 30, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5.05% of Matson Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 6.69% in Matson Inc. common stock as of March 31, 2026.
NYSE
The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Matson Inc. following an internal realignment on January 12, 2026.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.9% of Matson, Inc.'s common stock as of March 31, 2025.